Companies › LQDA
LIQUIDIA CORPORATION COM NEW (LQDA)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001819576 · EDGAR filings · Updated 2026-07-24
LIQUIDIA CORPORATION COM NEW (LQDA) has reported institutional ownership of 69.2%, with 243 institutional managers holding positions valued at $2.32B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.
Filings this week (2)
- 2026-07-24 — Insider transaction reported (Form 4)
- 2026-07-22 — Insider transaction reported (Form 4)
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-14 — Insider transaction reported (Form 4)
- 2026-07-14 — Insider transaction reported (Form 4)
- 2026-07-14 — Insider transaction reported (Form 4)
- 2026-07-14 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, LIQUIDIA CORPORATION COM NEW has 243 institutional holders and institutional ownership of 69.2%.
Insider activity
Insiders reported 179 transactions (0 buys, 96 sells) across 17 reporting insiders, with a net reported value of −$50.0M.
Data flags from SEC filings
Related companies
BIOCRYST PHARMACEUTICALS INC (BCRX) · LIFESTANCE HEALTH GROUP INC (LFST) · SYNDAX PHARMACEUTICALS INC (SNDX) · STOKE THERAPEUTICS INC (STOK) · CELLDEX THERAPEUTICS INC NEW (CLDX) · WARBY PARKER INC CL A COM (WRBY)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-24.